Product IntroductionBioactivity英文名:
DORA-22描述: DORA-22 是一种双食欲素受体拮抗剂,可改善轻度压力引起的失眠,对记忆的影响很小。
动物实验: Animals were first trained to remember the location of a hidden platform (acquisition) in the Morris Water Maze and then administered DORA-22 (10, 30, or 100 mg/kg doses) or vehicle control.?Animals were then subjected to a rodent insomnia model involving two exposures to dirty cages over a 6-hr time period (at time points 0 and 3 hr), followed immediately by a probe trial in which memory of the water maze platform location was evaluated[1].
体内活性: DORA-22, a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory.DORA-22 treatment improved the insomnia-related sleep disruption-wake was attenuated and NREM sleep was normalized.?REM sleep amounts were enhanced compared with vehicle treatment for one dose (30 mg/kg).?In the first hour of insomnia model exposure, DORA-22 promoted the number and average duration of NREM sleep spindles, which have been previously proposed to play a role in memory consolidation (all doses).?Water maze measures revealed probe trial performance improvement for select doses of DORA-22, including increased time spent in the platform quadrant (10 and 30 mg/kg) and time spent in platform location and number of platform crossings (10 mg/kg only).?In conclusion, DORA-22 treatment improved insomnia-related sleep disruption and memory consolidation deficits[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 10 mg/mL (23.56 mM)
关键字:
DORA-22 |
DORA 22 |
DORA22相关产品:
Seltorexant |
TCS 1102 |
TCS-OX2-29 |
Orexin B, rat, mouse Acetate |
Daridorexant hydrochloride |
IPSU |
SB-649868 |
Orexin 2 Receptor Agonist |
ACT-462206 |
MK-3697相关库:
Membrane Protein-targeted Compound Library |
Bioactive Compounds Library Max |
Neuronal Signaling Compound Library |
GPCR Compound Library |
Inhibitor Library |
Target-Focused Phenotypic Screening Library |
NO PAINS Compound Library |
Bioactive Compound Library